BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence
Psychopharmacology, ISSN: 0033-3158, Vol: 209, Issue: 2, Page: 213-215
2010
- 12Citations
- 35Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations12
- Citation Indexes12
- 12
- CrossRef9
- Captures35
- Readers35
- 35
Article Description
Rationale Alterations in the expression of neurotrophic growth factors like brain-derived neuronal factor (BDNF) and glial cell line-derived neuronal growth factor (GDNF) have been frequently associated with affective disorders. Indeed, benzodiazepine dependence is typically combined with affective disorders. Aim of the study was to investigate plasma levels of the neuronal growth factors BDNF and GDNF during benzodiazepine withdrawal in patients suffering from comorbidity of benzodiazepine dependence and depressive disorder. Methods In total, 11 patients were included in the study. Seven patients completed benzodiazepine withdrawal. Results We found that BDNF plasma levels were significantly increased in the benzodiazepine-dependent patients (p=0.011) compared to a healthy control group (14 ageand sex-matched persons) and decreased significantly (p=0.029) due to benzodiazepine withdrawal, whereas GDNF plasma levels did not differ (p=0.886) and change (p=0.180) significantly. Conclusion In conclusion, we assume that benzodiazepines may partly act by similar neurobiological mechanisms like antidepressant medication, which may explain the high frequency of benzodiazepine dependence in affective disorders. © Springer-Verlag 2010.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77952763890&origin=inward; http://dx.doi.org/10.1007/s00213-010-1781-3; http://www.ncbi.nlm.nih.gov/pubmed/20140603; http://link.springer.com/10.1007/s00213-010-1781-3; https://dx.doi.org/10.1007/s00213-010-1781-3; https://link.springer.com/article/10.1007/s00213-010-1781-3; http://www.springerlink.com/index/10.1007/s00213-010-1781-3; http://www.springerlink.com/index/pdf/10.1007/s00213-010-1781-3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know